Evidence map›Paper›PMID 19592494›Full record

ArticleThe Journal of biological chemistry2009

No specific subcellular localization of protein kinase C is required for cytotoxic T cell granule exocytosis.

Arun T Pores-Fernando, Michelle Y D Ranaghan, Adam Zweifach

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Arun T Pores-FernandoDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut 06269-3125, USA.
Michelle Y D Ranaghan
Adam Zweifach
University of Connecticut · US

Funding

Calcium and Cytotoxic T LymphocytesR01AI054839 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI ZWEIFACH, ADAM · 2003 to 2007
$1.6M
NIAID NIH HHS R01 AI054839
6 · The paper itself

Abstract

Cytotoxic T cells kill virus-infected cells and tumor cells by releasing lytic granules that contain cell-killing contents. Exocytosis requires calcium influx and protein kinase C (PKC) activation. Here, we extend our previous finding regarding the lack of isoform specificity of PKCs in the granule release step, showing that mutant constitutively active PKCdelta can substitute for phorbol esters and support exocytosis. PKCdelta, a novel PKC isoform, was recently shown to play a role in lytic granule reorientation. Surprisingly, however, our results suggested that mutant PKCdelta did not localize to the plasma membrane (PM). To test directly whether PKC has to be in the PM to drive exocytosis, we generated mutants of various PKC isoforms that were tethered either to the outer mitochondrial membrane or to the PM. Tethered mutant PKCdeltas were able to promote exocytosis as effectively as the untethered version. The substrates of PKCs involved in lytic granule exocytosis are currently unknown, but subcellular localization is believed to be a critical factor in determining PKC accessibility to substrates. That there is no requirement for specific PKC localization in lytic granule exocytosis may have important implications for the identity of PKC substrates.

Indexed as

ExocytosisCell Line, TumorCell MembraneComputer SimulationCytoplasmic GranulesDNA, ComplementaryHumansMitochondriaModels, BiologicalMutationProtein IsoformsProtein Kinase CProtein Kinase C-deltaT-Lymphocytes, CytotoxicTransfectionDNA, ComplementaryProtein IsoformsProtein Kinase CProtein Kinase C-delta

Identifiers

PMID19592494
PMCPMC2757214
OpenAlexW1997728725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.